logo

Every Week, the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full art[...]
In the present issue of BJUI, Clèment-Zhao et al. [1] have evaluated the safety profile of a 2-weekly regime of cabazitaxel (CBZ) at a dose of 16 mg/m2 in 43 patients with progress[...]
Every Month, the Editor-in-Chief selects an Article of the Month from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full a[...]
In this issue of BJU International, Jang et al. [1] investigate the perioperative and oncological outcomes of robot-assisted radical prostatectomy (RARP) in oligometastatic prostat[...]
Every Week the Editor-in-Chief selects an Article of the Week from the current issue of BJUI. The abstract is reproduced below and you can click on the button to read the full arti[...]
In this issue of BJU International, Karzai et al. [1] report the results of a phase I study of the anti-endoglin antibody TRC105 in patients with metastatic castration-resistant pr[...]
A phase I study of TRC105 anti-CD105 (endoglin) antibody in metastatic castration-resistant prostate cancer Fatima H. Karzai, Andrea B. Apolo, Liang Cao, Ravi A. Madan, David E. Ad[...]
This year’s final #urojc concluded with intense discussions on the role of local treatment (LT) in metastatic prostate cancer. One study author, @mbwilliams95 joined the conversati[...]
Authors: Gupta, Chaitali; Kumar, Rajeev   Corresponding Author: Shailesh Sahay, All India Institute of Medical Sciences, Urology, New Delhi, India.  Email: scsahay@rediffmail.[...]
We present the first reported case of metastatic type II papillary RCC with radiographic evidence of spontaneous regression at a non-pulmonary site of proven metastases. Authors: N[...]